Why Mankind (MNKD) Stock Is Up Today

NEW YORK (TheStreet) -- Mankind (MNKD) shares are up 3.3% to $10.11 on Friday after analysts at RBC Capital initiated coverage with an "outperform" rating and $16 price target on the company.

The price target represents a 60% upside over the company's opening price today.

Must ReadWarren Buffett's 25 Favorite Stocks 

With the rapid action insulin market currently valued at over $16 billion, the optimistic outlook rests on the shoulders of the company's potential breakthrough insulin inhaler Afrezza

The company's stock price fell yesterday however after it announced that an Afrezza partnership may not happen until 6-8 weeks after the drugs approval.

M Chart

M data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

More from Markets

Global Stocks Rebound But US-China Trade War Concerns Keep Investors on Edge

Global Stocks Rebound But US-China Trade War Concerns Keep Investors on Edge

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China